Search

everythinglearnresearchcommunity

for

Search:↓

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Certain cells outside the hair follicle's bulge area can quickly regenerate damaged hair follicles, potentially helping to reduce hair loss from cancer treatments.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Older people more commonly have skin conditions related to aging, and early treatment can improve their quality of life.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

Advanced human skin models improve drug development and could replace animal testing.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.